{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:28:22Z","timestamp":1792682902905,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-KH137917"],"award-info":[{"award-number":["RS-2023-KH137917"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05396-0","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:20:30Z","timestamp":1767018030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective study"],"prefix":"10.1007","volume":"176","author":[{"given":"Ye Sul","family":"Jeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Taek","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumsuk","family":"Keam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Kee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ah","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Hye","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"5396_CR1","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro-Oncol, 24(Supplement_5):v1\u2013v95","DOI":"10.1093\/neuonc\/noac202"},{"key":"5396_CR2","doi-asserted-by":"publisher","unstructured":"Harrison RA, Ou A, Naqvi S, Naqvi SM, Weathers SS, O\u2019Brien BJ et al (2021) Aggressiveness of care at end of life in patients with high-grade glioma. Cancer Med, 10(23):8387-8394. https:\/\/doi.org\/10.1002\/cam4.4344","DOI":"10.1002\/cam4.4344"},{"key":"5396_CR3","doi-asserted-by":"publisher","unstructured":"Brodbelt A, Greenberg D, Winters T, Williams M, Vernon S, Collins VP et al (2015) Glioblastoma in England: 2007\u20132011. Eur J Cancer, 51(4):533-542. https:\/\/doi.org\/10.1016\/j.ejca.2014.12.014","DOI":"10.1016\/j.ejca.2014.12.014"},{"key":"5396_CR4","doi-asserted-by":"publisher","unstructured":"Henriksen OM, Del Mar Alvarez-Torres M, Figueiredo P, Hangel G, Keil VC, Nechifor RE et al (2022) High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced mri techniques in the clinic, and the latest bench-to-bedside developments. Part 1: perfusion and diffusion techniques. Front Oncol, 12:810263. https:\/\/doi.org\/10.3389\/fonc.2022.810263","DOI":"10.3389\/fonc.2022.810263"},{"issue":"5","key":"5396_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/cns.15.31","volume":"4","author":"L Dirven","year":"2015","unstructured":"Dirven L, Sizoo EM, Taphoorn MJ (2015) Anaplastic gliomas: end-of-life care recommendations. CNS Oncol, 4(5):357\u2013365. https:\/\/doi.org\/10.2217\/cns.15.31","journal-title":"CNS Oncol"},{"key":"5396_CR6","doi-asserted-by":"publisher","unstructured":"Philip J, Collins A, Brand CA, Gold M, Moore G, Sundararajan V et al (2015) Health care professionals\u2019 perspectives of living and dying with primary malignant glioma: Implications for a unique cancer trajectory. Palliat Support Care, 13(6):1519-1527. https:\/\/doi.org\/10.1017\/S1478951513000576","DOI":"10.1017\/S1478951513000576"},{"key":"5396_CR7","doi-asserted-by":"publisher","unstructured":"Walbert T (2025) Palliative care in neuro-oncology. Continuum (Minneapolis, Minn.) 31(6):1657-1674. https:\/\/doi.org\/10.1212\/cont.0000000000001641","DOI":"10.1212\/cont.0000000000001641"},{"issue":"2","key":"5396_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejca.2011.11.010","volume":"48","author":"EM Sizoo","year":"2012","unstructured":"Sizoo EM, Pasman HRW, Buttolo J, Heimans JJ, Klein M, Deliens L et al (2012) Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer 48(2):226\u2013232","journal-title":"Eur J Cancer"},{"issue":"12","key":"5396_CR9","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/cancers13122867","volume":"13","author":"A Wu","year":"2021","unstructured":"Wu A, Ruiz Col\u00f3n G, Aslakson R, Pollom E, Patel CB (2021) Palliative care service utilization and advance care planning for adult glioblastoma patients: a systematic review. Cancers 13(12):2867","journal-title":"Cancers"},{"issue":"3","key":"5396_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11060-018-03015-9","volume":"140","author":"M IJzerman-Korevaar","year":"2018","unstructured":"IJzerman-Korevaar M, Snijders TJ, de Graeff A, Teunissen SC, de Vos FY (2018) Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol 140(3):485\u2013496","journal-title":"J Neurooncol"},{"issue":"6","key":"5396_CR11","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S1470-2045(17)30345-5","volume":"18","author":"A Pace","year":"2017","unstructured":"Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Ruda R et al (2017) European association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol 18(6):e330\u2013e340. https:\/\/doi.org\/10.1016\/S1470-2045(17)30345-5","journal-title":"Lancet Oncol"},{"key":"5396_CR12","doi-asserted-by":"publisher","unstructured":"Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35(1):96\u2013112. https:\/\/doi.org\/10.1200\/JCO.2016.70.1474","DOI":"10.1200\/JCO.2016.70.1474"},{"key":"5396_CR13","doi-asserted-by":"publisher","unstructured":"Philip P J, Collins A, Panozzo S, Staker J, Murphy M (2020) Mapping the nature of distress Raised by patients with high-grade glioma and their family caregivers: a descriptive longitudinal study. Neurooncol Pract, 7(1):103\u2013110. https:\/\/doi.org\/10.1093\/nop\/npz032","DOI":"10.1093\/nop\/npz032"},{"key":"5396_CR14","doi-asserted-by":"publisher","unstructured":"Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE et al (2023) Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol, 25(3):447-456. https:\/\/doi.org\/10.1093\/neuonc\/noac216","DOI":"10.1093\/neuonc\/noac216"},{"issue":"4","key":"5396_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/onco.13625","volume":"26","author":"D Hausner","year":"2021","unstructured":"Hausner D, Tricou C, Mathews J, Wadhwa D, Pope A, Swami N et al (2021) Timing of palliative care referral before and after evidence from trials supporting early palliative care. Oncologist 26(4):332\u2013340","journal-title":"Oncologist"},{"key":"5396_CR16","first-page":"68","volume":"180","author":"YJ Kim","year":"2023","unstructured":"Kim YJ, Kim S-H (2023) Advance care planning in South Korea. Zeitschrift f\u00fcr Evidenz, fortbildung und Qualit\u00e4t. Im Gesundheitswesen 180:68\u201373","journal-title":"Im Gesundheitswesen"},{"key":"5396_CR17","unstructured":"Treatment NAML-S (2025). Monthly statistics. https:\/\/www.lst.go.kr\/comm\/monthlyStatistics.do"},{"key":"5396_CR18","doi-asserted-by":"publisher","unstructured":"Sudore RL, Lum HD, You JJ, Hanson LC, Meier DE, Pantilat SZ et al (2017) Defining advance care planning for adults: A consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage 53(5):821\u2013832. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.12.331 e821","DOI":"10.1016\/j.jpainsymman.2016.12.331"},{"key":"5396_CR19","doi-asserted-by":"publisher","unstructured":"Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M et al (2017) Definition and recommendations for advance care planning: an international consensus supported by the European association for palliative care. Lancet Oncol 18(9):e543\u2013e551. https:\/\/doi.org\/10.1016\/S1470-2045(17)30582-X","DOI":"10.1016\/S1470-2045(17)30582-X"},{"key":"5396_CR20","doi-asserted-by":"publisher","unstructured":"Kim K, Park B, Gu B, Nam EJ, Kye SH, Choi JY (2022) The National hospice and palliative care registry in Korea. Epidemiol Health. 44:e2022079. https:\/\/doi.org\/10.4178\/epih.e2022079","DOI":"10.4178\/epih.e2022079"},{"key":"5396_CR21","doi-asserted-by":"publisher","unstructured":"Fritz L, Zwinkels H, Koekkoek JAF, Reijneveld JC, Vos MJ, Dirven L et al (2020) Advance care planning in glioblastoma patients: development of a disease-specific ACP program. Support Care Cancer, 28(3):1315-1324. https:\/\/doi.org\/10.1007\/s00520-019-04916-9","DOI":"10.1007\/s00520-019-04916-9"},{"issue":"1","key":"5396_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.6004\/jadpro.2021.12.1.7","volume":"12","author":"P Goswami","year":"2021","unstructured":"Goswami P (2021) Advance care planning and end-of-life communications: practical tips for oncology advanced practitioners. J Adv Pract Oncol 12(1):89\u201395. https:\/\/doi.org\/10.6004\/jadpro.2021.12.1.7","journal-title":"J Adv Pract Oncol"},{"key":"5396_CR23","doi-asserted-by":"publisher","unstructured":"Lee YJ, Kim SH, Yoo SH, Kim AS, Lin CP, Fhea et al (2024) Advance care planning in palliative care in Asia: barriers and implications. J Hosp Palliat Care, 27(4):107-119. https:\/\/doi.org\/10.14475\/jhpc.2024.27.4.107","DOI":"10.14475\/jhpc.2024.27.4.107"},{"issue":"3","key":"5396_CR24","first-page":"1315","volume":"28","author":"L Fritz","year":"2020","unstructured":"Fritz L, Zwinkels H, Koekkoek JA, Reijneveld JC, Vos MJ, Dirven L et al (2020) Advance care planning in glioblastoma patients: development of a disease-specific ACP program. Support Care Cancer 28(3):1315\u20131324","journal-title":"Support Care Cancer"},{"issue":"4","key":"5396_CR25","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/neuonc\/nox196","volume":"20","author":"D Forst","year":"2018","unstructured":"Forst D, Adams E, Nipp R, Martin A, El-Jawahri A, Aizer A et al (2018) Hospice utilization in patients with malignant gliomas. Neuro Oncol 20(4):538\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/nox196","journal-title":"Neuro Oncol"},{"key":"5396_CR26","doi-asserted-by":"publisher","unstructured":"Crooms RC, Taylor JW, Jette N, Morgenstern R, Agarwal P, Goldstein NE et al (2023) Palliative care referral across the disease trajectory in high-grade glioma. J Neurooncol, 163(1):249-259. https:\/\/doi.org\/10.1007\/s11060-023-04338-y","DOI":"10.1007\/s11060-023-04338-y"},{"issue":"23","key":"5396_CR27","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.1002\/cam4.4344","volume":"10","author":"RA Harrison","year":"2021","unstructured":"Harrison RA, Ou A, Naqvi SM, Naqvi SM, Weathers SPS, O\u2019Brien BJ et al (2021) Aggressiveness of care at end of life in patients with high-grade glioma. Cancer Med 10(23):8387\u20138394","journal-title":"Cancer Med"},{"issue":"1","key":"5396_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2217\/cns-2016-0013","volume":"6","author":"HS Birk","year":"2017","unstructured":"Birk HS, Han SJ, Butowski NA (2017) Treatment options for recurrent high-grade gliomas. CNS Oncol 6(1):61\u201370","journal-title":"CNS Oncol"},{"issue":"1","key":"5396_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/cancers17010146","volume":"17","author":"D Sipos","year":"2025","unstructured":"Sipos D, Raposa BL, Freihat O, Simon M, Mekis N, Cornacchione P et al (2025) Glioblastoma: clinical presentation, multidisciplinary management, and Long-Term outcomes. Cancers 17(1):146","journal-title":"Cancers"},{"key":"5396_CR30","doi-asserted-by":"publisher","unstructured":"Birk HS, Han SJ, Butowski NA (2017) Treatment options for recurrent high-grade gliomas. CNS Oncol, 6(1):61-70. https:\/\/doi.org\/10.2217\/cns-2016-0013","DOI":"10.2217\/cns-2016-0013"},{"issue":"1","key":"5396_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11060-025-05323-3","volume":"176","author":"J Drappatz","year":"2025","unstructured":"Drappatz J, Mantica M (2025) Treatment strategies and innovation for recurrent high-grade glioma. J Neurooncol 176(1):118. https:\/\/doi.org\/10.1007\/s11060-025-05323-3","journal-title":"J Neurooncol"},{"key":"5396_CR32","doi-asserted-by":"publisher","unstructured":"Barbaro M, Blinderman CD, Iwamoto FM, Kreisl TN, Welch MR, Odia Y et al (2022) Causes of death and end-of-life care in patients with intracranial high-grade gliomas: a retrospective observational study. Neurology, 98(3):e260-e266. https:\/\/doi.org\/10.1212\/WNL.0000000000013057","DOI":"10.1212\/WNL.0000000000013057"},{"key":"5396_CR33","doi-asserted-by":"publisher","unstructured":"Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ et al (2014) End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol, 120(2):303-310. https:\/\/doi.org\/10.1007\/s11060-014-1548-5","DOI":"10.1007\/s11060-014-1548-5"},{"key":"5396_CR34","doi-asserted-by":"publisher","unstructured":"Sundararajan V, Bohensky MA, Moore G, Brand CA, Lethborg C, Gold M et al (2014) Mapping the patterns of care, the receipt of palliative care and the site of death for patients with malignant glioma. J Neurooncol, 116(1):119-126. https:\/\/doi.org\/10.1007\/s11060-013-1263-7","DOI":"10.1007\/s11060-013-1263-7"},{"key":"5396_CR35","doi-asserted-by":"crossref","unstructured":"Kim W, Kim K, Nam EJ, Kye SH, Choi JY (2024) Trends and status of hospice use in South Korea (2018\u20132022)","DOI":"10.52937\/hira.24.4.1.e1"},{"key":"5396_CR36","doi-asserted-by":"publisher","unstructured":"Han YH, Yoo SH, Lee SY, Hwang IY, Kim KH, Cho B et al (2022) The medical needs and characteristics of cancer and progressive neurologic disease patients who use home-based medical care in Korea: a retrospective study for 2011\u20132020. J Am Med Dir Assoc, 23(10):1634\u20131641 e1632. https:\/\/doi.org\/10.1016\/j.jamda.2022.06.027","DOI":"10.1016\/j.jamda.2022.06.027"},{"key":"5396_CR37","doi-asserted-by":"publisher","unstructured":"Hwang IY, Han Y, Kim MS, Kim KH, Cho B, Choi W et al (2023) Preferred versus actual place of care and factors associated with home discharge among Korean patients with advanced cancer: a retrospective cohort study. Healthcare (Basel), 11(13). https:\/\/doi.org\/10.3390\/healthcare11131939","DOI":"10.3390\/healthcare11131939"},{"issue":"8","key":"5396_CR38","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.3346\/jkms.2025.40.e109","volume":"40","author":"CN Kim","year":"2025","unstructured":"Kim CN, Yoon SJ (2025) Reinforcing primary care in korea: policy Implications, data Sources, and research methods. J Korean Med Sci 40(8):e109. https:\/\/doi.org\/10.3346\/jkms.2025.40.e109","journal-title":"J Korean Med Sci"},{"issue":"1","key":"5396_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11060-011-0726-y","volume":"107","author":"CY Finocchiaro","year":"2012","unstructured":"Finocchiaro CY, Petruzzi A, Lamperti E, Botturi A, Gaviani P, Silvani A et al (2012) The burden of brain tumor: a single-institution study on psychological patterns in caregivers. J Neurooncol 107(1):175\u2013181. https:\/\/doi.org\/10.1007\/s11060-011-0726-y","journal-title":"J Neurooncol"},{"issue":"3","key":"5396_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-013-1069-7","volume":"112","author":"B Flechl","year":"2013","unstructured":"Flechl B, Ackerl M, Sax C, Oberndorfer S, Calabek B, Sizoo E et al (2013) The caregivers\u2019 perspective on the end-of-life phase of glioblastoma patients. J Neurooncol 112(3):403\u2013411. https:\/\/doi.org\/10.1007\/s11060-013-1069-7","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05396-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05396-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:12Z","timestamp":1769773632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05396-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5396"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05396-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 2305-088-1431), and the requirement for informed consent was waived due to the retrospective design and the use of de-identified data. All study procedures were carried out in accordance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"T.M.K.: Consultancy: AstraZeneca, BeOne Medicines, Daiichi Sankyo, Janssen, Merck KGaA, Novartis, Regeneron, Roche\/Genentech, Samsung Bioepis, and Chong Kun Dang Pharmaceutical; Honoraria: AstraZeneca\/MedImmune, Amgen, BeOne Medicines, Daiichi Sankyo, Janssen Research & Development, and Takeda. Otherwise, the authors have no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}